<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">
Blogs

Pharmacy News and Stories

Clinical Research

Press Coverage    Faculty    Clinical Research

Risks of marijuana and THC on the heart: What you need to know

Evidence suggests cannabis may be linked to certain heart problems. Are the risks from smoking marijuana, or is it the THC in weed that could be harmful? “I’m very worried,” said Robert Page, PharmD, “It’s looking like cannabis may be a risk factor for developing cardiovascular disease.”


Author NBC News | Publish Date November 18, 2023
Full Story

Press Coverage    Pharmacy    Clinical Research

Medicare Could Save an Additional $10 Billion Annually Across 10 Drugs by Using a Therapeutic Reference Pricing Approach in Upcoming Price Negotiations

“Medicare will begin negotiating prices for top-selling drugs in 2023, but since the United States does not have a public health technology assessment entity that determines comparative effectiveness, the Centers for Medicare & Medicaid Services will need to conduct its own assessments for the drugs being negotiated," said Michael J. DiStefano, PhD.


Author Newswise | Publish Date November 07, 2023
Full Story

Students    Clinical Research

Student Team Top 5 in National Clinical Research Challenge

A trio of PharmD students set a record this spring, taking fourth place at the American Colleges of Clinical Pharmacy (ACCP) Clinical Research Challenge (CRC) and clinching the highest win for any CU Pharmacy team in the history of the competition.


Author Jordan Kellerman | Publish Date July 01, 2023
Full Story

Pharmacy    Clinical Research    Podcast

The Power of Placebos

In an American College of Clinical Pharmacy (ACCP) journals podcast, Dr. Sara Wettergreen, PharmD, speaks on harnessing the power of placebos and mitigating nocebo effects. 


Author SOP Communications | Publish Date October 19, 2022
Full Story

Research    Alumni    Pharmacy    Clinical Research    Graduate Program

CU Pharmacy Alumnus Strategizes through PhD Program


Recently, we connected with Dr. Chong Kim (CK), who received his PhD in Pharmaceutical Outcomes during the fall 2020 Commencement on Dec. 12. Dr. Kim  describes himself as a critical thinking, highly motivated, and hard working problem solver. Currently, his specific interests lie in optimizing the landscape of the healthcare environment around the world. His main expertise involves observational studies, development of statistical methods, and programming. He's currently working as a manager at Stratevi.

Author Jaron Bryant | Publish Date May 28, 2021
Full Story

School of Pharmacy In the News

Medscape

Medical Cannabis for Chronic Pain Tied to Arrhythmia Risk

news outletMedscape
Publish DateFebruary 13, 2024

Adults using medical cannabis for chronic pain, especially those with cancer or cardiometabolic disease, have a slightly elevated risk of developing arrhythmia, according to an editorial by Robert Page, PharmD

Full Story
KDVR

Colorado company developing potential prescription psilocybin product

news outletKDVR
Publish DateJanuary 17, 2024

Dr. David Kroll, PhD, says right now psilocybin is listed as a schedule one drug with no medical benefit and a high potential for abuse. “So, it is a risky proposition for these companies," he said, "but the clinical trials that have come out to date have been so promising that these companies have been able to acquire investors."

Full Story
The Denver Post

Littleton company developing psilocybin microdosing drug in hopes of FDA approval

news outletThe Denver Post
Publish DateJanuary 09, 2024

Though they hope to gain FDA approval soon, it may take some time. Dr. David Kroll, PhD, said the company will have additional hurdles to clear with the agency. 

Full Story
Neurology Today

Neurology Drugs Are Getting Better—and More Expensive—With More Prior Authorization Hassles

news outletNeurology Today
Publish DateJanuary 04, 2024

“The payers are trying to squeeze wherever they can,” said Dr. Kavita Nair, PhD, FAAN, a neurology professor and pharmacy outcomes researcher at the University of Colorado and vice chair of the American Academy of Neurology's Coding and Payment Policy Subcommittee.

Full Story